Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and identification of agents which have efficacy for the treatment of cancer
US2014272947A1
Methods and compositions for screening modulators of oncogene-induced senescence
US2014050665A1
Method for the treatment or prophylaxis of lymphangioleiomyomatosis (lam) and animal model for use in lam research
US2013331294A1
Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
WO2013130417A1
Estrogen metabolite levels and cyp1b1 polymorphisms in lung cancer diagnosis, prognosis, and risk assessment
WO2013043581A1
Aromatherapy device
US2013004504A1
Method of modulating phenylalanine hydroxylase structure and function
EP2714083A1
Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
WO2012166579A1
Synergistic inhibition of erbb2/erbb3 signal pathways in the treatment of cancer
WO2013006230A2
Combined inhibition of the vitamin d receptor and dna replication in the treatment of cancer
WO2012135601A2
Systems for fusion of fluorescence molecular tomography and magnetic resonance images
WO2012129192A2
Mucin 5b as a pancreatic cyst fluid specific biomarker for accurate diagnosis of mucinous cysts and other markers useful for dection of pancreatic malignancy
WO2012122101A1
Methods for inhibiting proliferation and inducing apoptosis of cancer cells expressing the g protein-coupled estrogen receptor gpr30
WO2012112846A2
Systems and methods for diagnosing a predisposition to develop cancer
WO2012109540A1
Methods for inducing epithelial cancer cell senescence
WO2012097240A2
Systems and methods for diagnosing kidney cancer
WO2012088513A2
Inhibiting the integration of retrovirus dna into host cell dna and screening compounds capable of the same
WO2012078703A2
Inhibiting chromosome instability in ovarian cancer
WO2012075136A2
Targeting of cyp1b1 in the treatment of head and neck cancer and lung cancer
